Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 13 May 2016, 11:00 HKT/SGT
Share:
    

Source: A*STAR
New Technique Paves the Way for Drug Targeting to Fight Microbial Resistance
Technology opens possibilities for development of new anti-microbials, anti-virals or vaccines against infectious diseases such as dengue and Zika

SINGAPORE, May 13, 2016 - (ACN Newswire) - Research investigators in Singapore have developed a new high throughput method that identifies how ribonucleic acid (RNA) molecules come together in an unbiased and large-scale manner inside cells. Named SPLASH, or Sequencing of Psoralen Linked And Selected Hybrids, this newly-developed technique was used to describe the RNA network in human and yeast cells, its dynamics, and how the structural organisation impacts translation and decay processes in the cell.


The development was jointly led by Drs Wan Yue and Niranjan Nagarajan from A*STAR's Genome Institute of Singapore (GIS), and was published online on 12 May 2016 in Molecular Cell.

RNAs are key molecules that play important roles in regulating gene expression in a cell. While the scientific community has extensively studied how mini cellular machines such as proteins and chromatin fold and interact with each other over the past decades, lesser is known about how RNA come together to interact with itself or with other RNA molecules. This limitation prompted the team to come up with SPLASH to advance understanding of RNA interactions.

Dr Wan, co-lead author of the study and Junior Principal Investigator of Stem Cell & Regenerative Biology at the GIS said, "The cell is a complex machine; we need to understand the configuration of all its components to be able to engineer and/or repair it. RNA shapes and RNA interaction networks are key to cellular function. Depending on cellular needs, these dynamic interaction networks can be remodelled. Most importantly, targeting these networks could be a means to inhibit infectious organisms." Dr Wan received the prestigious Branco Weiss Fellowship in 2014 and the Young Scientist Award in 2015 for her work on antimicrobial resistance.

The method will allow the team to study the transcriptomes[1] of infectious organisms - including pathogenic bacteria, dengue and Zika viruses - to understand the way RNA shapes and networks in these genomes enable the infection of human cells by pathogens. It is hoped that these efforts in understanding microbial pathogenicity will contribute to new anti-microbials, anti-virals or vaccines against these pathogens.

"It is exciting to have a first comprehensive view of the RNA interactome and to capture its dynamics. We now have the tools to understand how RNA structural organization impacts disease and pathogen biology, with the eventual goal being to leverage this understanding for new drugs and antimicrobials," added Dr Nagarajan, the paper's co-lead author and Principal Investigator of Computational & Systems Biology at the GIS.

GIS Executive Director Prof Ng Huck Hui said, "Understanding RNA interaction networks and gene regulation is an area of intense interest for the scientific community. Prior to the development of SPLASH, few tools allowed researchers to delve deeper into this field of research. This method now opens the field to understand the dynamics of RNA interaction networks in diverse organisms. I am hopeful that it will help the community better understand how RNAs function in vivo and as a result, reap the benefits from their newly-gained insights."

[1] The transcriptome is the set of all RNA molecules in one cell or a population of cells.

NOTES:
The research findings described in this media release can be found in the scientific journal Molecular Cell, under the title, "In Vivo Mapping of Eukaryotic RNA Interactomes Reveals Principles of Higher-Order Organization and Regulation" by Jong Ghut Ashley Aw(1),(5), Yang Shen(2),(5), Andreas Wilm(2),(5), Miao Sun(2), Xin Ni Lim(1), Kum-Loong Boon(1), Sidika Tapsin(1), Yun-Shen Chan(1), Cheng-Peow Tan(1), Adelene Y.L. Sim(3), Tong Zhang(4), Teodorus Theo Susanto(1), Zhiyan Fu(2), Niranjan Nagarajan(2),*, and Yue Wan(1),*.

(1) Stem Cell and Regenerative Biology
(2) Computational and Systems Biology
Genome Institute of Singapore, A*STAR, Singapore 138672, Singapore
(3) Bioinformatics Institute, A*STAR, 30 Biopolis Street #07-01, Matrix 138671, Singapore
(4) Human Genetics, Genome Institute of Singapore, A*STAR, Singapore 138672, Singapore
(5) Co-first author
* Correspondence: nagarajann@gis.a-star.edu.sg (N.N.), wany@gis.a-star.edu.sg (Y.W.)

Full text of the Molecular Cell paper can be accessed online from: http://bit.ly/222Nv5A

IMAGE: http://bit.ly/1OqH18P
Source: A*STAR's Genome Institute of Singapore
Text: "RNA interactions can occur within a RNA molecule and between different RNAs. These interactions are captured in a global manner by the method Sequencing of Psoralen crosslinked, Ligated, and Selected Hybrids (SPLASH). mRNA-mRNA interactions are organised into interaction networks and reflect cellular compartmentalisation. These interactions can be dynamic and remodelled according to environmental factors (depicted as rain in the figure) such as differentiation."

About A*STAR's Genome Institute of Singapore (GIS)

The Genome Institute of Singapore (GIS) is an institute of the Agency for Science, Technology and Research (A*STAR). It has a global vision that seeks to use genomic sciences to achieve extraordinary improvements in human health and public prosperity. Established in 2000 as a centre for genomic discovery, the GIS will pursue the integration of technology, genetics and biology towards academic, economic and societal impact.

The key research areas at the GIS include Human Genetics, Infectious Diseases, Cancer Therapeutics and Stratified Oncology, Stem Cell and Regenerative Biology, Cancer Stem Cell Biology, Computational and Systems Biology, and Translational Research.

The genomics infrastructure at the GIS is utilised to train new scientific talent, to function as a bridge for academic and industrial research, and to explore scientific questions of high impact. For more information about GIS, please visit www.gis.a-star.edu.sg


Contact:
Joyce Ang
Senior Officer, Office of Corporate Communications
Genome Institute of Singapore, A*STAR
Tel: +65 6808 8101
Email: angjj@gis.a-star.edu.sg


Topic: Research and development
Source: A*STAR

Sectors: Science & Research, BioTech, BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



A*STAR
Dec 6, 2022 14:00 HKT/SGT
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
June 2, 2022 21:00 HKT/SGT
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
June 2, 2022 21:00 HKT/SGT
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Sept 30, 2021 16:00 HKT/SGT
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes
July 31, 2020 08:00 HKT/SGT
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials
July 24, 2020 17:00 HKT/SGT
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2
Oct 22, 2019 04:00 HKT/SGT
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology
June 28, 2019 08:00 HKT/SGT
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms
Apr 5, 2019 18:00 HKT/SGT
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow
Jan 21, 2019 13:00 HKT/SGT
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: